Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells
about
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsVariation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersIdentification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patientsSerum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitroEstablishment of HLA-DR4 transgenic mice for the identification of CD4+ T cell epitopes of tumor-associated antigensRole of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.DEPDC1 is a novel cell cycle related gene that regulates mitotic progressionPTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions.ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues.Kruppel-associated box (KRAB) proteins in the adaptive immune system.Human genetic variation and the risk of hepatocellular carcinoma development.Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.Targeted therapies in bladder cancer: an overview of in vivo research.A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy.Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathwayDEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma.Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.MED28 increases the colony-forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage.Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia.Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro.DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor κB signaling pathway in HepG2 cells.
P2860
Q28487347-46185DCC-28F7-4F14-BE92-969D7E801619Q28943479-B9E856AC-9574-4A19-9B7D-CB26CC4C9E7EQ34264912-76FCEC1A-310C-43C1-BF4E-1252B079C224Q35077264-6E03D494-23FA-4918-9C07-0C84EF028413Q35081098-3B36D70B-3749-4F54-9239-8A9857727E31Q35208006-18287DEB-237E-42F8-B2B7-CE8E929585D0Q36079472-B3144FD2-7E8E-4098-86F2-074740FC2060Q36126937-3E84DC60-1BFB-46E2-B069-6505C29123D9Q36534662-69935AE5-C247-4748-B105-7317E88CF6B0Q37065382-9FE28136-C8C4-4793-B3BE-48ABDE294450Q37327695-7770830F-F604-4F9D-9397-74385AB40B4EQ37522321-20834C6E-E4F6-4086-A126-C9FB6B0D1CCBQ38201977-94460979-A6B2-4EAD-9CC1-F2D90C919AA8Q38552272-A7C16C36-0D9A-4F91-A304-5EEB628087ADQ38563691-0F5E6FCE-7039-4186-A7C1-31CF87B53A12Q38590471-73E39B4E-7A8B-4C2F-94D0-28741B9658F8Q38969931-26316425-9B85-45F1-9BAD-F0EB6AC84EC1Q39321805-2E11DF1A-0F0C-4A42-9677-C3B0C9C29CFAQ41338135-29252D16-0BF5-46D9-812D-8744FE56AF91Q41586688-BBEE312C-ABE1-4EF7-8EF2-4D3A4C1C5C73Q42360091-048CDDF2-F287-472E-8A55-08CEEF943E9CQ42362706-1CE5857B-3313-4DDF-83FB-286D7833D155Q48363759-4736D1A8-9639-46A1-B5F6-507BD503EF0FQ49434689-A34D2F27-EDE9-4F4D-805A-28E90AE76821Q50979257-6E6B2646-7318-4680-A95D-36C4BEDCD92FQ52597543-A50F8A8F-ACD6-4A90-8C7D-D2E28A485D99Q55377445-DC3D3689-888C-4E0D-BB8C-8B39101AF1B2
P2860
Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@ast
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en-gb
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@nl
type
label
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@ast
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en-gb
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@nl
prefLabel
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@ast
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en-gb
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@nl
P2093
P921
P3181
P1433
P1476
Cell-permeable peptide DEPDC1- ...... nicity in bladder cancer cells
@en
P2093
Mitsugu Kanehira
Ryo Takata
Taro Shuin
Tomoaki Fujioka
Toyomasa Katagiri
Tsuneharu Miki
Yoshiko Fujisawa
Yosuke Harada
Yusuke Nakamura
P304
P3181
P356
10.1158/0008-5472.CAN-10-0255
P407
P577
2010-07-15T00:00:00Z